Global Pharma Grade Isosorbide Market Strategic Research Report

Scope of the Report

The global Pharma Grade Isosorbide market size is predicted to grow from US$ 65.13 million in 2025 to US$ 79.73 million in 2032; it is expected to grow at a CAGR of 3.0% from 2026 to 2032.

Pharmaceutical-grade isosorbide is a high-purity chemical substance used in the pharmaceutical field. Isosorbide is a diol extracted from plant-derived materials (such as corn starch) and belongs to the cyclic sugar alcohol family. It exhibits good biocompatibility and biodegradability. In the pharmaceutical industry, isosorbide and its derivatives are used to produce drugs for treating cardiovascular diseases, demonstrating good pharmacological activity and safety. Isosorbide is also an effective osmotic oral diuretic. The demand for pharmaceutical-grade isosorbide is estimated at approximately 5,500 tons in 2025.

In recent years, with the continuous development of the global pharmaceutical industry and the ongoing advancement of green chemistry concepts, the market demand for pharmaceutical-grade isosorbide, as an important high-purity bio-based chemical, has steadily increased. Isosorbide is mainly produced by the dehydration of sorbitol, derived from renewable biomass resources such as corn and starch. It possesses good biocompatibility, stability, and low toxicity, and has broad application prospects in pharmaceutical intermediates, pharmaceutical excipients, and functional chemicals. Against the backdrop of the global pharmaceutical industry's increasing demand for high-purity, safe, and sustainable raw materials, the pharmaceutical-grade isosorbide market has gradually attracted attention.

From a demand structure perspective, pharmaceutical intermediates are one of the main application areas for pharmaceutical-grade isosorbide, widely used in the production of cardiovascular drugs such as isosorbide nitrate. Simultaneously, with the development of high-end pharmaceutical formulations and the biopharmaceutical industry, the demand for high-purity bio-based excipients continues to grow, driving the expansion of the pharmaceutical-grade isosorbide market. In some functional formulations and specialty drug systems, isosorbide can also be used as a stabilizer, solvent, or functional additive, providing better safety and stability for the product.

From a technological perspective, the industry is moving towards higher purity, continuous production, and green processes, improving product consistency and yield through optimized catalytic systems and refining processes. Simultaneously, with increasingly stringent global pharmaceutical regulations, product quality control and GMP production capabilities have become crucial competitive factors.

In terms of the industry chain, upstream suppliers include bio-based raw material suppliers such as glucose and sorbitol; midstream is isosorbide producers; and downstream are pharmaceutical intermediate manufacturers and pharmaceutical companies. The industry as a whole has high technological barriers, especially in high-purity refining and quality control, placing high demands on companies' R&D and manufacturing capabilities. As the pharmaceutical industry increasingly focuses on green raw materials and sustainable supply chains, companies with large-scale and high-standard production capabilities hold a leading position in the market.

From a regional market perspective, Europe and North America have stable demand in the high-end pharmaceutical and bio-based chemical sectors, with high requirements for product quality and certification. The Asia-Pacific region has become the fastest-growing region driven by the rapid development of the pharmaceutical manufacturing industry, with significant market potential in China, India, and Japan. Latin America and the Middle East are experiencing gradual demand growth against the backdrop of pharmaceutical industry expansion. Overall, the global market exhibits a parallel development pattern of "high-end + green."

Looking ahead, the global pharmaceutical-grade isosorbide market will be driven by three core factors: first, the continued growth in demand for pharmaceutical intermediates and high-end formulations; second, the strengthening trend of green pharmaceutical manufacturing and bio-based chemicals; and third, the continuous upgrading of high-purity production processes and quality standards. Market growth is not only reflected in the expansion of demand, but also in the increased value brought about by high-value-added pharmaceutical applications.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharma Grade Isosorbide market?

What factors are driving Pharma Grade Isosorbide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharma Grade Isosorbide market opportunities vary by end market size?

How does Pharma Grade Isosorbide break out by Type, by Application?

This report presents a comprehensive overview of the global Pharma Grade Isosorbide market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• 99.5%
• 99%

Segment by Application

• Cardiovascular Drugs
• Dehydration Diuretics
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pharma Grade Isosorbide market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Cardiovascular Drugs, Dehydration Diuretics, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact